A major factor that can affect the success of a patient recruitment project is the number of people who express an interest in participating, but are then unable to be contacted to arrange an initial site visit.

In many of the trials I’ve worked on, this can represent well over half the people who submit an application. Which obviously leads to a reduced number of potential participants – even though these are people who are aware of the trial and want to take part.

In order to reduce this number of ‘non-contactable’ people, a swift follow-up to their initial application is key. For immediate engagement, this follow-up method can be done by automated text or online chat (whether live or via a chatbot). Each of which methods enables instant interaction with the person volunteering for the trial, which can significantly increase the likelihood of them becoming a participant.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...